• About
  • Planning for the Future: Evaluating Exit Strategies in Biopharma

Planning for the Future: Evaluating Exit Strategies in Biopharma

  • 25 Jun 2026
  • 4:00 PM - 7:00 PM
  • 12 Gill St., Woburn, MA 01801

Registration


Register

Understanding the pros and cons of IPO vs. M&A for small to mid-sized biopharma companies looking to grow or expand their science

Thursday, June 25, 2026
4:00–7:00 p.m.

12 Gill Street
Woburn, MA 01801

Speakers:

  • Tracy Curley: Goal-driven executive, former CEO and CFO iSpecimen, and financial strategist
  • John Hession: Senior advisor to emerging companies, angel investor, and legal advisor
  • Moderated by Naomi Vishnupad: 

Event Details: 

Join this small panel of experts in an intimate conversation about the pros and cons of the various options available to the start-up biopharma industry. Planning for the future of your organization can be daunting; key factors to consider are financial, legal, and the impacts to you, your people and your intellectual property. This discussion will provide a framework for understanding the options and helping to clarify the benefits and pitfalls so you can be better prepared for what may come.

North Shore Technology Council is a 501(c)6 non-profit organization. 100 Cummings Center, Suite 223-F Beverly, MA 01915.

Contact us at administrator@nstc.org.


Powered by Wild Apricot Membership Software